Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation?Positive Child. (2019)
Attributed to:
The effect of AIP mutations on the apoptotic RET pathway in pituitary adenomas
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1210/jc.2019-00432
PubMed Identifier: 31125088
Publication URI: http://europepmc.org/abstract/MED/31125088
Type: Journal Article/Review
Volume: 104
Parent Publication: The Journal of clinical endocrinology and metabolism
Issue: 8
ISSN: 0021-972X